Articles tagged with Vaccination
A new study reveals the second dose of a COVID-19 vaccine induces powerful immune system responses, including broad antiviral protection and enhanced innate immunity. The research strongly supports skipping the second dose, as it stimulates a manifold increase in antibody levels and a terrific T-cell response.
Researchers developed a θ-SIR model to simulate the impact of SARS-CoV-2 strains and vaccines on COVID-19 propagation. The model estimates that insufficient vaccination rates can lead to new waves, even with effective reproduction numbers below 1.
A small UCSF study found that COVID-19 mRNA vaccines were not detected in human milk, providing early evidence of vaccine safety during breastfeeding. The study analyzed seven women and their children and found no trace of the vaccine in breast milk.
A recent study published in the Disaster Medicine and Public Health Preparedness journal explores negative dominance of COVID-19 vaccine-related information online. The researchers found that compared to all other content, posts focused on adverse events pale in comparison to posts promoting positive messages about vaccines.
A new study published in Nature Medicine reveals that willingness to get a COVID-19 vaccine is higher in developing countries, with personal protection being the main reason for acceptance. Concern about side effects was the most common reason for vaccine hesitancy, but health workers were considered trusted sources of information.
A new protein-based vaccine candidate combined with a potent adjuvant has shown effective protection against SARS-CoV-2 in animal studies. The combination improved antibody and T cell responses, reducing viral load and inflammation.
A qualitative study found that fear, illness, and loss motivated information seeking and mitigation behaviors in Black and Latinx participants during the pandemic. Vaccine skepticism was high, with mistrust linked to racism and medical experimentation.
A Rutgers study found Black and Latinx people seek information on COVID-19 safety measures, such as mask-wearing and testing, due to pandemic experiences. However, they are skeptical about vaccines due to concerns over rapid development, side effects, and lack of transparent information.
Primary care physicians provide the largest share of services for vaccinations and majority of clinical visits for vaccination, making them well-positioned to administer COVID-19 vaccines. They can also answer vaccine questions and provide clinical guidance on interpreting results from COVID-19 testing and immunity determinations.
A UCSF study found that 83% of respondents aged 18-25 had not been vaccinated, with concerns over side effects and safety leading to low vaccination rates. The researchers recommend addressing these concerns through public education campaigns to encourage young adult vaccination.
A new study published in Science Translational Medicine reports on the protection offered by Ebola vaccines. The research found that different vaccine platforms conferred varying levels of protection, with RBD-specific antibodies and Fc-mediated immune functions playing key roles.
Research suggests that fungi in the healthy gut can have a beneficial effect on health, while invasive forms may contribute to inflammatory bowel disease. Vaccines targeting specific proteins may help restore balance to the microbiome.
A new study published in PLOS Medicine found a spatial relationship between COVID-19 mortality and population-level health and socioeconomic indicators. The researchers identified 9 key indicators, including chronic kidney disease and nursing home prevalence, which had the largest individual effect on COVID-19 mortality rates.
Researchers found a nearly 35,000% increase in COVID-19 vaccine and infertility Google searches following a misinformation event. The study highlights the dangers of misinformation campaigns on public perception and decision-making, particularly among pregnant patients.
A new study published in PAIN found that what parents say in the first minute after a vaccine is crucial in reducing children's distress. The researchers recommend keeping kids calm with physical strategies and delaying verbal coping statements until they're over initial distress.
A recent study by Columbia University's Mailman School of Public Health found that 43% of US COVID-19 mortality variability is linked to county-level socioeconomic indicators and health vulnerabilities. Allocating vaccines to these areas could minimize severe outcomes, particularly deaths. The research suggests a correlation between he...
A single dose of the Sputnik V vaccine elicits significant antibody responses against SARS-CoV-2, with 94% of participants developing IgG antibodies within three weeks. Previously infected individuals show higher antibody levels after one dose compared to fully vaccinated volunteers.
A new study found that fully vaccinated care home residents are still at risk of COVID-19, with the vaccine being less effective in older adults. The study showed that unvaccinated residents were three times more likely to develop the infection than those who had received two doses of the vaccine.
A survey study examined COVID-19 vaccine acceptance and approaches to improve vaccination rates among Chinese adults. The study found significant disparities in vaccine uptake, with regional differences in attitudes towards vaccination.
Researchers found that vaccination significantly increases neutralizing antibodies in saliva, reducing transmission risk. The study also shows the importance of receiving a second vaccine dose for maximum protection against evolving virus strains.
The Delta variant is less sensitive to neutralizing antibodies compared to the Alpha variant, with serum from convalescent patients showing reduced potency. Vaccinated individuals' sera effectively neutralize the Delta variant, although efficacy is slightly lower than against the Alpha variant.
The CoronaVac vaccine demonstrated 83.5% protection against symptomatic COVID-19 and 100% effectiveness against hospitalization in a phase 3 trial. The study involved adults aged 18-59 and showed high efficacy with a very good safety profile, but further data is needed on the vaccine's long-term effects and efficacy against new variants.
A California study suggests that partnering with black churches and medical professionals can increase COVID-19 vaccine uptake in black communities. The study found that a three-tier approach to mobile vaccination clinics, involving faith leaders and pharmacists, resulted in a significant increase in vaccine uptake among blacks.
Researchers developed a biomaterial-based infection vaccine (ciVAX) approach to combat infectious diseases. ciVAX vaccines combine two technologies that capture immunogenic antigens from pathogens and reprogram the immune system, offering potential solutions for sepsis prophylaxis, pandemic threats, and biothreats.
A new study found that patients taking immunosuppressants like methotrexate had weaker antibody responses to the Pfizer COVID-19 vaccine after the first dose. However, T-cell responses were preserved in these patients, suggesting potential risks and benefits of vaccinating immunocompromised individuals.
A single-center study reports a decline in COVID-19 cases among healthcare workers after vaccination, indicating the vaccine's effectiveness in preventing disease transmission. The study suggests that vaccination can reduce the risk of infection among healthcare workers, thereby protecting both patients and healthcare staff.
Experts debate whether COVID-19 vaccination should be delayed in children due to unclear benefits and risks. Vulnerable people worldwide should be prioritized instead, but some argue that children should not be disadvantaged.
A recent study published in JAMA Oncology found that the Pfizer-BioNTech vaccine appears to be safe and effective in patients with cancer, achieving satisfactory serologic status. Despite a lag in antibody production compared to non-cancer control groups, most patients experienced seroconversion after the second dose.
New research shows that open communication about vaccine effectiveness and side effects boosts trust in health authorities, reducing hesitancy and conspiracy theories. Vague or reassuring communication, on the other hand, lowers acceptance of vaccines.
Researchers discovered the molecular mechanism behind vaccine-induced immune thrombotic thrombocytopenia (VITT), a rare but fatal blood clotting disorder. The findings will enable the development of rapid diagnostic tests and new strategies to prevent VITT, making vaccines safer.
The Obesity Society's new position statement confirms COVID-19 vaccines are highly efficacious in individuals with and without obesity. Trials demonstrate similar vaccine efficacy in both groups against COVID-19-associated hospitalization and death.
Researchers developed hybrid membrane nanovaccines that educate patients' immune systems to distinguish tumor components as 'non-self', preventing recurrence and metastasis. The vaccines induce robust innate and adaptive immune responses, offering a new opportunity for individualized cancer vaccines.
Scientists successfully engineered a 'vaccine' using harmless commensal bacteria to prepare immune cells for a life-threatening disease. The approach showed promise in inducing immunity without adverse effects, paving the way for novel treatments and applications.
A study found no detection of COVID-19 vaccine-associated messenger RNA (mRNA) in breast milk samples from vaccinated mothers. Researchers analyzed 13 human milk samples and concluded that the mRNA was not detectable.
A new study led by a University at Buffalo researcher shows that the way news media talk about science focuses too much attention on individuals, leading to inaccurate perceptions of scientific accuracy and reliability. The study suggests that contextualizing failure stories within the scientific process can help ameliorate harm to sci...
A nationwide study found mRNA COVID-19 vaccines significantly reduce the risk of infection by up to 91% in fully vaccinated individuals. For those who develop breakthrough cases, vaccines also shorten symptom duration and severity.
Most COVID-19 patients develop and maintain T cell memory for over 10 months, suggesting effective long-term immunity. The study provides new insights into vaccine development by revealing the self-renewal capacity and multipotency of memory T cells.
A new study found that only 20 out of 51 US states included health equity committees in their COVID-19 vaccine distribution plans, with only 8 representing minority groups. The study highlights the need for standardized processes to address existing healthcare disparities and ensure equitable access to vaccines.
A study evaluated how US states and DC planned to ensure equitable COVID-19 vaccine distribution. The authors found that many plans lacked specific details on how to address health disparities, highlighting a need for improved strategies.
Recent evidence suggests diminished immune response to COVID-19 vaccines among immunosuppressed individuals. Researchers argue that developing targeted vaccination strategies is crucial to protect vulnerable populations and control new variant spread.
A recent study found that nearly all patients with cancer developed good immune responses to COVID-19 mRNA vaccines, with 94% developing antibodies. However, a small subset of high-risk patients showed no response, raising concerns about future vaccination strategies.
Researchers found that vaccinated individuals have a lower viral load, shorter infection time and milder symptoms than unvaccinated people. The study also showed a significant reduction in the risk of having COVID-19 with an accompanying fever.
A new Finnish study found that healthcare workers who received two doses of the Pfizer-BioNTech vaccine had strong antibody responses to SARS-CoV-2, with similar effectiveness against the alpha variant as the original virus. The immune response was weaker against the beta variant, but still provided relatively good protection.
The UK's official list of COVID-19 symptoms is too narrow, say experts, and expanding it could help identify more cases sooner. This would require careful implementation, but new data suggests that testing people based on combinations of unofficial and official symptoms could be used to achieve this.
A novel adjuvant developed with NIH funding has contributed to the success of COVAXIN, a highly efficacious COVID-19 vaccine. The adjuvant, Alhydroxiquim-II, has been shown to activate key immune receptors and stimulate an effective response against the virus.
A new study found that many young adult cancer survivors are reluctant to obtain COVID-19 vaccinations due to concerns about their weakened immune systems. The study suggests that cancer survivors, particularly females and those with lower education levels, may be more hesitant to receive vaccines.
Researchers found 23 men in the U.S. military developed severe chest pain and elevated cardiac troponin levels within four days of receiving a second dose of mRNA COVID-19 vaccines, but most recovered quickly. The risk of myocarditis from vaccination is low compared to COVID-19 infection.
New research shows that early testing for blood clots in AstraZeneca/Oxford vaccine recipients led to successful treatment of patients. The study emphasizes the importance of increased clinical vigilance to detect symptoms among vaccinated individuals.
A recent study reports four cases of acute myocarditis following mRNA COVID-19 vaccination. The condition can lead to serious heart problems, highlighting the need for cautious monitoring and research into vaccine safety.
A new paper proposes actions to increase access, speed time to market, and decrease costs of vaccines globally. Regulatory harmonization, manufacturing capacity building, and streamlined IP arrangements are key opportunities to address challenges in vaccine development and deployment.
A study found 23 cases of myocarditis in US military members following mRNA COVID-19 vaccination, highlighting a potential risk factor for the condition.
The Spanish Foundation for Science and Technology's third Social Perception Survey reveals that 83% of the population trusts COVID-19 vaccination, a 25-point increase from January. Attitudes towards vaccine uptake have improved significantly since July 2020, with compliance with COVID-19 preventive measures also showing a positive trend.
Researchers found that COVID-19 vaccines induce a robust and potentially long-lasting immune response with the formation of germinal centers in lymph nodes. Vaccination led to high levels of neutralizing antibodies effective against three variants of the virus, including the Beta variant from South Africa.
A single case report describes a 65-year-old man who developed thrombocytopenia with thrombosis following COVID-19 mRNA vaccination, highlighting the need for increased awareness and vigilance. The authors conclude that while rare events may occur, the benefits of vaccination should not be dissuaded.
A study published in Cancer Cell found that multiple myeloma patients exhibited a widely variable response to COVID-19 vaccines, with some showing undetectable antibodies after mRNA vaccines. This variation underscores the importance of routine blood tests and continued precautions for these patients.
A randomised controlled trial of 550 young people found two doses of CoronaVac to be safe and provoke a strong antibody response. Most adverse reactions were mild or moderate, with pain at the injection site being the most commonly reported symptom.
The MucoRice-CTB vaccine, a new edible cholera vaccine made from genetically modified rice, has shown no obvious side effects and a good immune response in its Phase 1 human trial. The vaccine stimulates the mucosal immune system through the gut to induce antigen-specific antibodies, producing IgG and IgA responses.
Researchers from Massachusetts General Hospital found that the BCG vaccine significantly lowers blood sugar levels in type 1 diabetics, with faster response times and greater changes in HbA1c for younger patients. The vaccine also restores gene expression in regulatory T cells over three years.
A new study reveals structural changes in the Alpha and Beta SARS-CoV-2 variants, suggesting reduced effectiveness of current vaccines against the Beta variant. The research found that mutations in the Beta variant change the shape of the spike surface, making it less bind to neutralizing antibodies.
The NIH's MOMI-VAX study aims to assess antibody responses, transfer of antibodies to infants, and vaccine safety in vaccinated participants and their newborns. The study will enroll up to 750 pregnant individuals and 250 postpartum individuals, followed through the first year after delivery.